Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose esomeprazole with or without baclofen in therapy-resistant gastroesophageal reflux disease
2006-000368-10Phase 2Terminated
- Sponsor
- Technical University of Munich
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of esomeprazole and baclofen in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Technical University of Munich. Started Mar 2006; status: terminated.
02
Drugs
esomeprazolebaclofen
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-000368-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000368-10.